Cover Image
市場調查報告書

次世代定序 (NGS)的全球市場預測 2022年:目標重定序、RNA定序、外顯子定序、De Novo定序

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application - Global Forecasts to 2022

出版商 MarketsandMarkets 商品編碼 235782
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
Back to Top
次世代定序 (NGS)的全球市場預測 2022年:目標重定序、RNA定序、外顯子定序、De Novo定序 Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application - Global Forecasts to 2022
出版日期: 2017年04月04日 內容資訊: 英文 216 Pages
簡介

全球次世代定序 (NGS) 市場,預計從2017到2022年以20.5%的年複合成長率發展,到2022年達到124億5,000萬美元。

本報告以次世代定序 (NGS)的全球市場為焦點,提供全球的成長展望,產品與服務,應用,及各地區該市場的現狀及預測數值彙整,產品開發趨勢和競爭環境,主要企業等相關的最新資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 次世代定序 (NGS) :市場概要
  • NGS市場:各產品 & 服務
  • NGS市場規模:各應用領域
  • NGS市場:各終端用戶
  • 地區分析:各NGS市場規模,產品與服務

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 機會
    • 課題
    • 產業趨勢

第6章 次世代定序 (NGS) 市場:各產品與服務

  • 簡介
  • 預定序產品與服務
    • 樣品製作
  • NGS平台、消耗品、平台的服務
    • NGS平台市場
  • 定序服務
    • 目標重定序
    • RNA定序
    • De Novo定序
    • 外顯子定序
    • 晶片定序
    • 全基因定序
    • 甲基化定序
    • 其他
  • NGS資料分析、儲存、管理 (生物資訊學)
    • NGS資料分析軟體及工作台
    • NGS資料分析服務
    • NGS儲存,經營管理及雲端運算解決方案

第7章 次世代定序 (NGS) 市場:各技術

  • 簡介
  • 合成法定序 (SBS)
  • 離子半導體定序
  • 一分子即時定序 (SMART)
  • 奈米細孔定序

第8章 次世代定序 (NGS) 市場:各應用領域

  • 簡介
  • 診斷
  • 藥物研發
  • 生物標記探索
  • 精密醫療
  • 農業 & 動物研究
  • 其他應用

第9章 次世代定序 (NGS) 市場:各終端用戶

  • 簡介
  • 研究中心及學問&政府機關
  • 醫院 & 診所
  • 醫藥品 & 生物科技企業
  • 其他終端用戶

第10章 次世代定序 (NGS) 市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區 (ROW)

第11章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第12章 企業簡介

  • 簡介
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • QIAGEN N.V.
  • BEIJING GENOMICS INSTITUTE
  • PERKINELMER, INC.
  • F. HOFFMANN-LA ROCHE AG
  • AGILENT TECHNOLOGIES, INC.
  • GATC BIOTECH AG
  • OXFORD NANOPORE TECHNOLOGIES, LTD.
  • MACROGEN, INC.
  • EUROFINS SCIENTIFIC

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2697

The global next-generation sequencing market is estimated to register a CAGR of 20.5% from 2017 to 2022 to reach USD 12.45 billion by 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.

On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.

On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina's systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.

Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.

On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its BaseSpace Clarity LIMS in Mayo's specific laboratories.

Geographically, the NGS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2017, followed by Europe. The market in North America is primarily driven by the technological advancements, availability of commercial solutions for NGS data analysis, and the strong presence of key players in this region. However, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022, due to the improving healthcare infrastructure and favorable government initiatives in this region.

The global NGS market is highly competitive, with a large number of global and local players. In 2016, the global NGS market was dominated by Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), and together held the majority share of the NGS platforms market. New product launches, product enhancements, agreements, and partnerships were the major strategies adopted by market players to achieve growth in the market.

Research Coverage:

This report studies the next-generation sequencing (NGS) market based on product & service, application, technology, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis-industry trends, market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the next-generation sequencing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios and services offered by the major players in the next-generation sequencing market. The report analyzes the next generation sequencing market based on product & service, application, technology, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the next-generation sequencing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various next-generation sequencing products and services across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the next-generation sequencing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the next-generation sequencing market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. RESEARCH DESIGN
  • 2.3. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.3.1. SECONDARY RESEARCH
      • 2.3.1.1. Key data from secondary sources
    • 2.3.2. PRIMARY DATA
      • 2.3.2.1. Breakdown of primaries
      • 2.3.2.2. Key data from primary sources
      • 2.3.2.3. Key industry insights
  • 2.4. MARKET SIZE ESTIMATION
      • 2.4.1.1. Bottom-up approach
      • 2.4.1.2. Top-down approach
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

  • 4.1. NEXT-GENERATION SEQUENCING (NGS): MARKET OVERVIEW
  • 4.2. NGS MARKET, BY PRODUCT & SERVICE (2017 VS. 2022)
  • 4.3. NGS MARKET SIZE, BY APPLICATION, 2017 VS. 2022
  • 4.4. NGS MARKET, BY END USER (2017 VS. 2022)
  • 4.5. GEOGRAPHIC ANALYSIS: NGS MARKET SIZE, BY PRODUCT & SERVICE (2017 VS. 2022), USD MILLION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements in sequencing platforms
      • 5.2.1.2. Increasing applications of NGS
      • 5.2.1.3. Growing number of partnerships and collaborations
      • 5.2.1.4. Increasing adoption of NGS technologies among research laboratories and academic institutes
      • 5.2.1.5. Conferences and workshops increasing awareness on NGS products and services
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Dearth of skilled professionals
      • 5.2.2.2. Difficulties in storage of sequencing data
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Government initiatives in population sequencing
      • 5.2.3.2. Application of NGS in precision medicine & biomarker discovery
      • 5.2.3.3. Emerging markets offer significant growth opportunities
      • 5.2.3.4. Cloud computing, a prospective service
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Interpretation of complex data from NGS platforms
      • 5.2.4.2. Accuracy & standardization concerns in diagnostic testing
      • 5.2.4.3. Issues related to the security of NGS data
    • 5.2.5. INDUSTRY TRENDS
      • 5.2.5.1. Integration of next-generation sequencing with cloud-based technology
      • 5.2.5.2. Focus on cancer research
      • 5.2.5.3. Mergers and acquisitions
      • 5.2.5.4. Entry of new market players

6. NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. PRE-SEQUENCING PRODUCTS & SERVICES MARKET
    • 6.2.1. SAMPLE PREPARATION
      • 6.2.1.1. DNA fragmentation, end repair, A-tailing, and size selection
      • 6.2.1.2. Library preparation & target enrichment
      • 6.2.1.3. Quality control
  • 6.3. NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS
    • 6.3.1. NGS PLATFORMS MARKET
      • 6.3.1.1. Illumina
        • 6.3.1.1.1. HiSeq Series
        • 6.3.1.1.2. HiSeq X Ten & HiSeq X Five
        • 6.3.1.1.3. MiSeq Series
        • 6.3.1.1.4. NextSeq 500
        • 6.3.1.1.5. MiniSeq
      • 6.3.1.2. Thermo fisher scientific (life technologies)
        • 6.3.1.2.1. Ion PGM
        • 6.3.1.2.2. Ion Proton
        • 6.3.1.2.3. Ion S5 & S5 XL
      • 6.3.1.3. Pacific Biosciences
        • 6.3.1.3.1. PacBio RS II
        • 6.3.1.3.2. Sequel System
      • 6.3.1.4. Oxford nanopore technologies
      • 6.3.1.5. Other next-generation sequencing platforms
      • 6.3.1.6. Recently launched sequencing platforms
  • 6.4. SEQUENCING SERVICES MARKET
    • 6.4.1. TARGETED RE-SEQUENCING
    • 6.4.2. RNA-SEQ
    • 6.4.3. DE NOVO SEQUENCING
    • 6.4.4. EXOME SEQUENCING
    • 6.4.5. CHIP-SEQ
    • 6.4.6. WHOLE-GENOME SEQUENCING
    • 6.4.7. METHYL-SEQ
    • 6.4.8. OTHER APPLICATIONS
  • 6.5. NGS DATA ANALYSIS, STORAGE, AND MANAGEMENT (BIOINFORMATICS)
    • 6.5.1. NGS DATA ANALYSIS SOFTWARE & WORKBENCHES
    • 6.5.2. NGS DATA ANALYSIS SERVICES
    • 6.5.3. NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS

7. NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
  • 7.2. SEQUENCING BY SYNTHESIS
  • 7.3. ION SEMICONDUCTOR SEQUENCING
  • 7.4. SINGLE-MOLECULE REAL-TIME SEQUENCING
  • 7.5. NANOPORE SEQUENCING

8. NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. DIAGNOSTICS
  • 8.3. DRUG DISCOVERY
  • 8.4. BIOMARKER DISCOVERY
  • 8.5. PRECISION MEDICINE
  • 8.6. AGRICULTURE & ANIMAL RESEARCH
  • 8.7. OTHER APPLICATIONS

9. NEXT-GENERATION SEQUENCING MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  • 9.3. HOSPITALS & CLINICS
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.5. OTHER END USERS

10. NEXT-GENERATION SEQUENCING MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Favorable government funding scenario in the U.S. market
      • 10.2.1.2. Growing focus of NGS market players on strengthening their presence in the U.S.
      • 10.2.1.3. Increasing number of NGS conferences in the U.S.
    • 10.2.2. CANADA
      • 10.2.2.1. Favorable government funding scenario in Canada
      • 10.2.2.2. Growing focus of market players on expanding their presence in Canada
  • 10.3. EUROPE
    • 10.3.1. MARKET PLAYERS ARE CAPITALIZING ON OPPORTUNITIES IN THE EUROPEAN NGS MARKET
      • 10.3.1.1. Launch of new and advanced products and services
      • 10.3.1.2. Partnerships/ agreements/ collaborations
    • 10.3.2. GERMANY, U.K., AND BELGIUM: MAJOR HUBS FOR SCIENTIFIC RESEARCH
    • 10.3.3. GROWING FUNDING AND INVESTMENT FOR NGS IN EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. GROWING FOCUS OF DOMESTIC AND MULTINATIONAL PLAYERS ON THE ASIA-PACIFIC MARKET
      • 10.4.1.1. Launch of advanced NGS products and services
      • 10.4.1.2. Partnerships/ collaborations/ agreements to co-develop advanced NGS products and services
    • 10.4.2. FAVORABLE GOVERNMENT FUNDING SCENARIO
    • 10.4.3. CONFERENCES/ SEMINARS/ TRAINING PROGRAMS
  • 10.5. REST OF THE WORLD (ROW)
    • 10.5.1. FOCUS OF KEY MARKET PLAYERS ON EXPANDING THEIR PRESENCE IN ROW COUNTRIES
    • 10.5.2. WORKSHOPS AND CONFERENCES
    • 10.5.3. FAVORABLE INITIATIVES BY PUBLIC AND PRIVATE ORGANIZATIONS

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND SERVICE LAUNCHES
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS
    • 11.3.3. MERGERS AND ACQUISITIONS
    • 11.3.4. EXPANSIONS
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
    • 12.1.1. GEOGRAPHIC BENCHMARKING
  • 12.2. ILLUMINA, INC.
  • 12.3. THERMO FISHER SCIENTIFIC INC.
  • 12.4. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • 12.5. QIAGEN N.V.
  • 12.6. BEIJING GENOMICS INSTITUTE
  • 12.7. PERKINELMER, INC.
  • 12.8. F. HOFFMANN-LA ROCHE AG
  • 12.9. AGILENT TECHNOLOGIES, INC.
  • 12.10. GATC BIOTECH AG
  • 12.11. OXFORD NANOPORE TECHNOLOGIES, LTD.
  • 12.12. MACROGEN, INC.
  • 12.13. EUROFINS SCIENTIFIC

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: LIST OF SEQUENCING PLATFORMS LAUNCHED BY MARKET PLAYERS DURING 2015-2017
  • TABLE 2: NEW MARKET PLAYERS AND THEIR SEQUENCING PLATFORMS
  • TABLE 3: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 4: PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: DNA FRAGMENTATION, END REPAIR, A-TAILING, & SIZE SELECTION MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: LIBRARY PREPARATION & TARGET ENRICHMENT MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: QUALITY CONTROL MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: NGS INSTRUMENTS, CONSUMABLES, AND SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 10: NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NGS CONSUMABLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: NGS SERVICES FOR NGS SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: ILLUMINA NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 14: ILLUMINA NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: HISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: HISEQ X TEN & HISEQ X FIVE PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: MISEQ SERIES PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NEXTSEQ 500 PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: MINISEQ PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 21: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: ION PGM PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: ION PROTON PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: ION S5 & S5 XL PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 26: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: PACBIO RS II PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: SEQUEL SYSTEM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: OTHER NGS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: SEQUENCING SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 34: NGS BIOINFORMATICS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: DATA ANALYSIS SERVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY
  • TABLE 38: GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 39: SEQUENCING BY SYNTHESIS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: ION SEMICONDUCTOR SEQUENCING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: NANOPORE SEQUENCING MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: NEXT-GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 44: NEXT-GENERATION SEQUENCING MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 45: NEXT-GENERATION SEQUENCING MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 46: NEXT-GENERATION SEQUENCING MARKET SIZE FOR BIOMARKER DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 47: NEXT-GENERATION SEQUENCING MARKET SIZE FOR PRECISION MEDICINE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: NEXT-GENERATION SEQUENCING MARKET SIZE FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 49: NEXT-GENERATION SEQUENCING MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 50: NEXT-GENERATION SEQUENCING MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 51: NGS MARKET SIZE FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 52: NEXT-GENERATION SEQUENCING MARKET SIZE FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 53: NEXT-GENERATION SEQUENCING MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 54: NEXT-GENERATION SEQUENCING MARKET SIZE FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 55: NGS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 57: NORTH AMERICA: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: NORTH AMERICA: ILLUMINA NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: NORTH AMERICA: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: NORTH AMERICA: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: NORTH AMERICA: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: NORTH AMERICA: NGS MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: NORTH AMERICA: NGS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: NORTH AMERICA: NGS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 65: EUROPE: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: EUROPE: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: EUROPE: ILLUMINA NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: EUROPE: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: EUROPE: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: EUROPE: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 71: EUROPE: NGS MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 72: EUROPE: NGS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: NGS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: ILLUMINA NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ASIA-PACIFIC: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: ASIA-PACIFIC: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: ASIA-PACIFIC: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 80: ASIA-PACIFIC: NGS MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: NGS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: ASIA-PACIFIC: NGS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: NGS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 84: ROW: NGS PRE-SEQUENCING PRODUCTS & SERVICES MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: ROW: ILLUMINA NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: ROW: THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: ROW: PACIFIC BIOSCIENCES NGS PLATFORMS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 88: ROW: NGS BIOINFORMATICS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 89: ROW: NGS MARKET SIZE, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 90: ROW: NGS MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 91: ROW: NGS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 92: TOP FIVE PRODUCT LAUNCHES, PRODUCT ENHANCEMENTS, AND SERVICE LAUNCHES 2016-2017 (JANUARY)
  • TABLE 93: TOP FIVE AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2016-2017 (JANUARY)
  • TABLE 94: TOP FIVE MERGERS AND ACQUISITIONS, 2015-2017 (JANUARY)
  • TABLE 95: TOP GEOGRAPHIC EXPANSIONS, 2016
  • TABLE 96: TOP FIVE OTHER DEVELOPMENTS, 2015-2017 (JANUARY)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NEXT-GENERATION SEQUENCING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: NGS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: NGS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: NGS MARKET: DATA TRIANGULATION
  • FIGURE 6: GLOBAL NGS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 7: GLOBAL NGS PLATFORMS MARKET, 2017 VS. 2022
  • FIGURE 8: GLOBAL NGS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: GLOBAL NGS MARKET, BY REGION, 2016 (USD MILLION)
  • FIGURE 10: NGS MARKET IS EXPECTED TO REGISTER A HIGH, DOUBLE-DIGIT GROWTH RATE IN THE FORECAST PERIOD (2017-2022)
  • FIGURE 11: PRE-SEQUENCING PRODUCTS & SERVICES SEGMENT IS EXPECTED TO REGISTER THE HIGHEST CAGR BETWEEN 2017 & 2022
  • FIGURE 12: DIAGNOSTICS APPLICATION WILL CONTINUE TO DOMINATE THE NGS MARKET UNTIL 2022
  • FIGURE 13: RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NGS MARKET IN THE FORECAST PERIOD
  • FIGURE 14: CONSUMABLES IS EXPECTED TO BE THE DOMINANT PRODUCT SEGMENT IN ALL REGIONS IN THE FORECAST PERIOD
  • FIGURE 15: NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NANOPORE SEQUENCING IS EXPECTED TO REGISTER THE HIGHEST CAGR DURING 2017 TO 2022
  • FIGURE 17: DIAGNOSTICS APPLICATION SEGMENT IS EXPECTED TO CONTINUE TO DOMINATE THE GLOBAL NGS MARKET UNTIL 2022 (USD MILLION)
  • FIGURE 18: HOSPITALS & CLINICS SEGMENT IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 19: GLOBAL NGS MARKET OVERVIEW
  • FIGURE 20: NORTH AMERICA: NGS MARKET SNAPSHOT
  • FIGURE 21: EUROPE: NGS MARKET SNAPSHOT
  • FIGURE 22: ASIA-PACIFIC: NGS MARKET SNAPSHOT
  • FIGURE 23: ROW: NGS MARKET SNAPSHOT
  • FIGURE 24: LEADING MARKET PLAYERS HAVE ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE PAST THREE YEARS (2014 TO JANUARY 2017)
  • FIGURE 25: GLOBAL NGS PLATFORM MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 26: GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS* (2016)
  • FIGURE 27: ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 28: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 29: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 30: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 31: PERKINELMER, INC.: COMPANY SNAPSHOT (2015) 181  
  • FIGURE 32: ROCHE HOLDING AG: COMPANY SNAPSHOT (2016)
  • FIGURE 33: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 34: MACROGEN, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 35: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2016)
Back to Top